Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial

NCT01113372 is registered in ClinicalTrials.gov with Cardiovascular Research Center, Brazil as lead sponsor.

NCT NCT01113372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01113372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Duration of Clopidogrel Therapy Following Treatment With the Endeavor Zotarolimus - Eluting Stent in the Real World Clinical Practice - Optimize Trial
Lead sponsor
Cardiovascular Research Center, Brazil
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2015
Enrollment
3,119 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease